ISB News

ISB Undergrad Intern Publishes Paper in Journal

Lena Joesch-Cohen

Congratulations to Lena Joesch-Cohen (pictured above), who was one of ISB’s 2016 summer undergrad interns, just published a paper on the project she completed with Gustavo Glusman (Principal Scientist, Hood Lab). “Differences between the genomes of lymphoblastoid cell lines and blood-derived samples” was published on Feb. 23, 2017, in Dove Press. In a recommendation letter that Gustavo wrote to support Lena, he said this:

“Lena is an outstanding scholar. Despite having interned with me just after her first year of college, she essentially performed at doctoral level. Let me give one example of this. Less than one month into her internship, I was temporarily absent for family reasons. As I was about to leave, Lena told me she had completed all the analyses we had outlined; pressed for time, I suggested she start documenting the work. When I returned to the lab a couple of days later, Lena had penned a first draft of a manuscript describing her project! A scholarly introduction with references, the methods used, preliminary results with figures, and an outline of discussion points were all there.”

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.